SHIELD JA - Strategies for Health Interventions to Eliminate Infection related Cancer
SHIELD JA - Strategies for Health Interventions to Eliminate Infection related Cancer
- Project date: 01 NOVEMBER 2025 TO 31 OCTOBER 2028
- Contact person: Dr. Angelo Maria Pezzullo
- Call for applications: EU4H-2024-JA-IBA-03
- Project Code: PRJ-1335
- Coordinatore: University of Copenhagen
- Ente finanziatore: UNIONE EUROPEA
- Link: https://chip.dk/research-areas/public-health/studies-and-projects/shield-ja/
The main objective of the Joint Action "Strategies for Health Interventions to Eliminate Infection related Cancer" (SHIELD) is to reduce premature morbidity and mortality caused by communicable diseases, in particular cancers associated with infections and those preventable by vaccination. Combining different strategies into a comprehensive and effective prevention programme requires coordination between multiple and diverse stakeholders, including civil society, public health authorities and institutions, social support structures, health systems and the scientific community. A central aspect will be the identification and overcoming of possible barriers, both structural and individual, that hinder the effectiveness of programmes, as well as the identification, development, transfer and implementation of promising practices. SHIELD aims to define an effective programme at European level, combining complementary expertise already active in this area. The project responds to the priorities of the call by analysing how to ensure the large-scale implementation of all relevant preventive measures in different countries and identifying the barriers that hinder their implementation, both structurally and individually, with particular attention to the role of stigma and discrimination, especially in relation to HIV but also to other infections. Through the application of analytical models, SHIELD also aims to determine the optimal combination of preventive measures to be taken in different countries and contexts. The approach starts from the integrated consideration of all prevention strategies – primary, secondary and tertiary – rather than from the sole focus on vaccination coverage, in order to maximize the impact of the available options in the reduction of cancers caused by infections.
Project coordinator contact details:
CHIP, Rigshospitalet, Denmark
Email: shield.rigshospitalet@regionh.dk
Funding statement
"Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them."
SHIELD Consortium
The SHIELD consortium includes:
- Denmark - Capital Region of Denmark (RH/CHIP) Affiliated entities: RH/CHIP will engage with 4 AEs The Region of Southern Denmark (RSYD), Statens Serum Institut (SSI) & Central Denmark Region, Aarhus University Hospital AUH) and Sundhedsstyrelsen (SST)
- Belgium - Sciensano (SCI) Affiliated entities: Sciensano will engage with 2 AEs University on Antwerp (UA) and Vlaanderen – Department Zorg (BE-Dep.Zorg VL)
- Bosnia and Herzegovina - PHI University Clinical Center of Republika Srpska (UKC RS)
- Croatia - Croatian Institute of Public Health (CIPH)Affiliated entities: HZJZ will engage with 3 AEs Teaching Institute of Public Health of Split and Dalmatian County (TIPH SDC), Andrija Stampar Teaching Institute of Public Health (ASTIPH), Public Health Institute od Dubrovnik-Neretva County (PHi Dubrovnik)
- Cyprus - Department of Medical and Public Health Services of the Ministry of Health Cyprus (MPHS) Affiliated entities: MPHS will engage with 1 AE Cyprus University of Technology (CUT)
- Czechia - The National Institute of Public Health (SZÚ)
- Estonia - National Institute for Health Development (TAI) Affiliated entities: TAI will engage with 2 AEs Estonian Health Board (EHB) and University of Tartu (UniTartu)
- France – INSERM (INSERM)
- France - Ministère de la Santé et de l'accès aux soins (DGS)
- Finnish Institute of Health and Welfare (THL)
- Germany - Federal Institute of Public Health (BIÖG)
- Germany – Robert Koch Institute (RKI)
- Greece - Ethnikos Organismos Dimosias Ygeias (National Public Health Organisation, EODY) Affiliated entities: EODY will engage with 1 AE National and Kapodistrian University of Athens (NKUA)
- Hungary - National Directorate General for Hospitals (NDGH/OKFO) Affiliated entities: NDGH/OKFO will engage with 1 AE National Center for Public Health and Pharmacy (NNGYK)
- Italy – Istituto Superiore di Sanità (ISS) Affiliated entities: ISS will engage with 12 AEs Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo (UNIPA), University of Padova – Department of Surgical, Oncological and Gastroenterological Sciences (UNIPD), University of Cassino and Southern Lazio (UNICLAM), IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO), University of Naples Federico II, Department of Clinical Medicine and Surgery (UNINA), Sapienza - University of Rome, Department of Public Health and Infectious Diseases (UNIROMA1), Liguria Region (Reg Lig), University of Pisa (UNIPI), Catholic University of the Sacred Heart (UCSC), Reggio Emilia Local Health Unit (AUSL RE), Institute for the Study, Prevention and Oncology Network (ISPRO), Lombardy Region (Reg Lom)
- Latvia - Riga Stradins University (RSU)
- Lithuania – Ministry of health of the Republic of Lithuania (SAM LT) Affiliated entities: SAM LT will engage with 1 AE National Public Health Center (NVSC)
- Lithuania - Vilnius University Faculty of Medicine (VU)
- Malta – Ministry for Health and Active agening (MHA)
- Moldova – National Agency for Public Health (NAPH)
- Netherlands - Amsterdam Universitair Medisch Centrum (AUMC)
- Norway - Norwegian Institute of Public Health (NIPH)
- Poland - National Institute of Public Health NIH - National Research Institute (NIPH NIH – NRI)
- Romania – National Institute of Public Health (NIPH)
- Spain Institut Català d'Oncologia (ICO) Affiliated entities: ICO will engage with 2 AEs Universitat de Barcelona (UB), Secretariat for Public Health/Public Health Agency of Catalonia (GENCAT)
- Spain - Dirección General de Salud Pública y Equidad en Salud del Ministerio de Sanidad de España (DGSPyES) Affiliated entities: DGSPyES will engage with 1 AE Fundación CSAI (FCSAI)
- Sweden - Folkhälsomyndigheten / Public Health Agency of Sweden (PHAS) Affiliated entities: PHAS will engage with 4 AE Socialstyrelsen/The National Board of Health and Welfare (SoS), Karolinska Instituttet (KI), Region Stockholm/Karolinska University Hospital (Reg Sto), Region Uppsala / Uppsala Akademiska Sjukhus (REG UPS)
- Ukraine - Public Health Center of the Ministry of Health of Ukraine (PHC)
- Ukraine - National Cancer institute of the Ministry of Health of Ukraine (NCI)
- Bosnia and Herzegovina - Institute for Public Health of the Federation of Bosnia and Herzegovina (PHI-FBIH)
- Portugal – Directorate_General of Health (DGS) Affiliated entities: DGS will engage with 2 AEs Instituto de Saúde Pública da Universidade do Porto (ISPUP) and Unidade Local de Saúde de Santo António (ULSSA)
Associated Partners:
- Italy- University of Florence (UniFi)
- Bosnia and Herzegovina – The Ministry of Health and Social Welfare of Republika Srpska (MoH SRPSKA)
